DK0882726T3 - Carbazolcarboxamider som 5-HT1F-agonister - Google Patents
Carbazolcarboxamider som 5-HT1F-agonisterInfo
- Publication number
- DK0882726T3 DK0882726T3 DK98304343T DK98304343T DK0882726T3 DK 0882726 T3 DK0882726 T3 DK 0882726T3 DK 98304343 T DK98304343 T DK 98304343T DK 98304343 T DK98304343 T DK 98304343T DK 0882726 T3 DK0882726 T3 DK 0882726T3
- Authority
- DK
- Denmark
- Prior art keywords
- carboxamides
- carbazole
- ht1f agonists
- ht1f
- agonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Polyamides (AREA)
- Semiconductor Integrated Circuits (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Internal Circuitry In Semiconductor Integrated Circuit Devices (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Insulating Materials (AREA)
- Conductive Materials (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4858497P | 1997-06-04 | 1997-06-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0882726T3 true DK0882726T3 (da) | 2003-09-22 |
Family
ID=21955349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98304343T DK0882726T3 (da) | 1997-06-04 | 1998-06-02 | Carbazolcarboxamider som 5-HT1F-agonister |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0882726B1 (fr) |
JP (1) | JP2002502419A (fr) |
KR (1) | KR20010013409A (fr) |
CN (1) | CN1259049A (fr) |
AT (1) | ATE240953T1 (fr) |
AU (1) | AU729786B2 (fr) |
BR (1) | BR9810610A (fr) |
CA (1) | CA2291624A1 (fr) |
DE (1) | DE69814735T2 (fr) |
DK (1) | DK0882726T3 (fr) |
EA (1) | EA001718B1 (fr) |
ES (1) | ES2199410T3 (fr) |
HU (1) | HUP0004142A3 (fr) |
ID (1) | ID23053A (fr) |
IL (1) | IL133279A0 (fr) |
NO (1) | NO995963L (fr) |
NZ (1) | NZ501569A (fr) |
PL (1) | PL337221A1 (fr) |
PT (1) | PT882726E (fr) |
TR (1) | TR199903014T2 (fr) |
WO (1) | WO1998055115A1 (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1937300A (en) * | 1998-12-11 | 2000-06-26 | Eli Lilly And Company | Indole derivatives and their use as 5-HT1F agonists |
AU3840000A (en) | 1999-04-20 | 2000-11-02 | Meiji Seika Kaisha Ltd. | Tricyclic compounds |
DE60037321T4 (de) | 1999-08-04 | 2010-01-07 | Icagen, Inc. | Benzanilide als öffner des kaliumkanals |
US6495550B2 (en) | 1999-08-04 | 2002-12-17 | Icagen, Inc. | Pyridine-substituted benzanilides as potassium ion channel openers |
NZ516743A (en) * | 1999-08-04 | 2004-02-27 | Icagen Inc | Methods for treating or preventing pain and anxiety |
TWI263497B (en) | 2002-03-29 | 2006-10-11 | Lilly Co Eli | Pyridinoylpiperidines as 5-HT1F agonists |
BRPI0409211A (pt) | 2003-04-18 | 2006-03-28 | Lilly Co Eli | composto, composição farmacêutica, métodos para ativar receptores 5-ht1f, para inibir extravasão de proteìna neuronial, e para o tratamento ou prevenção de enxaqueca em um mamìfero, e, uso de um composto |
UA82711C2 (en) | 2003-09-12 | 2008-05-12 | Эли Лилли Энд Компани | Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists |
US7312236B2 (en) | 2003-12-17 | 2007-12-25 | Eli Lilly And Company | Substituted (4-aminocyclohexen-1-yl)phenyl and (4-aminocyclohexen-1-yl)pyridinyl compounds as 5-HT1F agonists |
EP1923387B1 (fr) * | 2005-08-08 | 2011-10-19 | Astellas Pharma Inc. | Dérivé d'acylguanidine ou sel de celui-ci |
CA2677995A1 (fr) * | 2007-02-07 | 2008-08-14 | Astellas Pharma Inc. | Derive d'acylguanidine |
MY183111A (en) * | 2010-03-22 | 2021-02-15 | Idorsia Pharmaceuticals Ltd | 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators |
US8697876B2 (en) | 2010-04-02 | 2014-04-15 | Colucid Pharmaceuticals, Inc. | Compositions and methods of synthesis of pyridinolypiperidine 5-HT1F agonists |
RU2015145135A (ru) * | 2013-04-09 | 2017-05-12 | Крессет Биомолекьюлар Дискавери Лтд | Лечение воспалительных расстройств |
TWI776175B (zh) | 2019-07-09 | 2022-09-01 | 美商美國禮來大藥廠 | 大規模製備2,4,6-三氟-n-[6-(1-甲基-哌啶-4-羰基)-吡啶-2-基]-苯甲醯胺半琥珀酸鹽的方法及中間體,以及2,4,6-三氟-n-[6-(1-甲基-哌啶-4-羰基)-吡啶-2-基]-苯甲醯胺醋酸鹽之製備 |
CN112125836A (zh) * | 2020-10-15 | 2020-12-25 | 濮阳惠成电子材料股份有限公司 | 有机电致光电材料中间体n-苯基咔唑-3-羧酸乙酯的合成方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9226566D0 (en) * | 1992-12-21 | 1993-02-17 | Smithkline Beecham Plc | Compounds |
US5521196A (en) * | 1994-10-05 | 1996-05-28 | Eli Lilly And Company | 5-HT1F agonists for the treatment of migraine |
NZ305166A (en) * | 1995-03-20 | 1998-12-23 | Lilly Co Eli | 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles; preparation and medicaments |
DE69610793T2 (de) * | 1995-06-23 | 2001-05-03 | Eli Lilly And Co., Indianapolis | 6-Subsitituierte-1,2,3,4-tetrahydro-9H-Carbazole und 7-substituierte-1OH-Cyclohepta(7,6-B)-Indole |
-
1998
- 1998-01-06 ID IDW991411A patent/ID23053A/id unknown
- 1998-06-01 NZ NZ501569A patent/NZ501569A/en unknown
- 1998-06-01 BR BR9810610-4A patent/BR9810610A/pt not_active IP Right Cessation
- 1998-06-01 HU HU0004142A patent/HUP0004142A3/hu unknown
- 1998-06-01 EA EA199901113A patent/EA001718B1/ru not_active IP Right Cessation
- 1998-06-01 TR TR1999/03014T patent/TR199903014T2/xx unknown
- 1998-06-01 WO PCT/US1998/003340 patent/WO1998055115A1/fr not_active Application Discontinuation
- 1998-06-01 AU AU77955/98A patent/AU729786B2/en not_active Ceased
- 1998-06-01 KR KR19997011410A patent/KR20010013409A/fr not_active Application Discontinuation
- 1998-06-01 JP JP50237299A patent/JP2002502419A/ja not_active Ceased
- 1998-06-01 PL PL98337221A patent/PL337221A1/xx unknown
- 1998-06-01 CN CN98805776A patent/CN1259049A/zh active Pending
- 1998-06-01 IL IL13327998A patent/IL133279A0/xx unknown
- 1998-06-01 CA CA002291624A patent/CA2291624A1/fr not_active Abandoned
- 1998-06-02 AT AT98304343T patent/ATE240953T1/de not_active IP Right Cessation
- 1998-06-02 DK DK98304343T patent/DK0882726T3/da active
- 1998-06-02 ES ES98304343T patent/ES2199410T3/es not_active Expired - Lifetime
- 1998-06-02 EP EP98304343A patent/EP0882726B1/fr not_active Expired - Lifetime
- 1998-06-02 PT PT98304343T patent/PT882726E/pt unknown
- 1998-06-02 DE DE69814735T patent/DE69814735T2/de not_active Expired - Fee Related
-
1999
- 1999-12-03 NO NO995963A patent/NO995963L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1259049A (zh) | 2000-07-05 |
TR199903014T2 (xx) | 2000-05-22 |
NZ501569A (en) | 2001-11-30 |
DE69814735T2 (de) | 2004-03-25 |
NO995963D0 (no) | 1999-12-03 |
AU729786B2 (en) | 2001-02-08 |
DE69814735D1 (de) | 2003-06-26 |
JP2002502419A (ja) | 2002-01-22 |
KR20010013409A (fr) | 2001-02-26 |
EA199901113A1 (ru) | 2000-08-28 |
BR9810610A (pt) | 2000-09-12 |
ATE240953T1 (de) | 2003-06-15 |
PL337221A1 (en) | 2000-08-14 |
EP0882726A1 (fr) | 1998-12-09 |
HUP0004142A2 (hu) | 2001-05-28 |
EA001718B1 (ru) | 2001-08-27 |
WO1998055115A1 (fr) | 1998-12-10 |
NO995963L (no) | 1999-12-03 |
CA2291624A1 (fr) | 1998-12-10 |
IL133279A0 (en) | 2001-04-30 |
AU7795598A (en) | 1998-12-21 |
EP0882726B1 (fr) | 2003-05-21 |
HUP0004142A3 (en) | 2002-10-28 |
ID23053A (id) | 2000-01-20 |
PT882726E (pt) | 2003-09-30 |
ES2199410T3 (es) | 2004-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE253063T1 (de) | 5-ht1f-agonisten | |
DK1204654T3 (da) | Benzofurylpiperaziner og benzofurylhomopiperaziner: Serotonin agonister | |
DK0882726T3 (da) | Carbazolcarboxamider som 5-HT1F-agonister | |
CA2354023A1 (fr) | Derives phenylglyciniques | |
ES2194960T3 (es) | N-(2-sustituido-3-(2-aminoetil)-1h-indol-5-il)-amidas como nuevos agonistas de 5-ht1f. | |
ES2182234T3 (es) | Inhibidores de metaloproteasa. | |
BR9808491A (pt) | Compostos calcilìticos | |
FI920023A0 (fi) | Heteroarylpiperazinfoereningar som antipsykotiska aemnen. | |
ATE126509T1 (de) | Disäuren von diarylstyrylchinolin. | |
ATE416157T1 (de) | Inhibitoren von integrin alpha-v-beta-6 | |
DK0810220T3 (da) | Arylacrylamidderivater som 5-HT1-agonister eller -antagonister | |
DK1204659T3 (da) | Serotonerge benzofuraner | |
NO20002408D0 (no) | 5-HT1F antagonister | |
MXPA02011234A (es) | Nuevas bases de oxidacion 2,5-diaminopiridina utiles para el tinte de las fibras queratinicas. | |
BR9902096A (pt) | Pitazóis. | |
ID27656A (id) | Turunan azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya | |
ATE261962T1 (de) | Benzonaphtyridin-1,8 derivate | |
ID27964A (id) | Turuna-azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya |